Lv1
42 积分 2025-05-15 加入
Spinal presentations in children with spinal muscular atrophy type 1 following gene therapy treatment with onasemnogene abeparvovec – The SMA REACH UK network experience
2天前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
3天前
已完结
British Thoracic Society guideline for respiratory management of children with neuromuscular weakness
4天前
已完结
Early treatment of type II SMA slows rate of progression of scoliosis
11天前
已完结
Hip Displacement in Spinal Muscular Atrophy: The Influences of Genetic Severity, Functional Level, and Disease-modifying Treatments
16天前
已完结
Spinal presentations in children with Spinal Muscular Atrophy type 1 following Gene Therapy treatment with onasemnogene abeparvovec – the SMA REACH UK network experience
16天前
已关闭
Scoliosis Development in Spinal Muscular Atrophy: The Influences of Genetic Severity, Functional Level, and Disease-Modifying Treatments
16天前
已完结
French-Belgian consensus statement to managing spinal deformities in children with spinal muscular atrophy treated with SMN restoring therapies
25天前
已完结
Motor Function and Safety of Nusinersen and Risdiplam in Asian Patients with Types 2–4 Spinal Muscular Atrophy (SMA): A Systematic Review and Meta-Analysis
26天前
已完结
From Symptom Palliation to Disease Modification : Implications for Dementia Care
2个月前
已关闭
皖公网安备34019202002308
